Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era
Articolo
Data di Pubblicazione:
2021
Citazione:
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era / Toss, A., Isca, C., Venturelli, M., Nasso, C., Ficarra, G., Bellelli, V., Armocida, C., Barbieri, E., Cortesi, L., Moscetti, L., Piacentini, F., Omarini, C., Andreotti, A., Gambini, A., Battista, R., Dominici, M., Tazzioli, G.. - In: ESMO OPEN. - ISSN 2059-7029. - 6:2(2021), pp. 1-6. [10.1016/j.esmoop.2021.100055]
Abstract:
The present analysis aims to evaluate the consequences of a 2-month interruption of mammographic screening on breast cancer (BC) stage at diagnosis and upfront treatments in a region of Northern Italy highly affected by the severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) virus.
Tipologia CRIS:
Articolo su rivista
Keywords:
COVID-19; breast cancer; mammographic screening; stage at diagnosis
Elenco autori:
Toss, A; Isca, C; Venturelli, M; Nasso, C; Ficarra, G; Bellelli, V; Armocida, C; Barbieri, E; Cortesi, L; Moscetti, L; Piacentini, F; Omarini, C; Andreotti, A; Gambini, A; Battista, R; Dominici, M; Tazzioli, G
Link alla scheda completa:
Link al Full Text:
Pubblicato in: